Subscribe to our Newsletters !!

    Kumar Jeetendra

    Research reveals portable digital chest drainage systems could help minimise spread of COVID-19

    London, UK – 10 December 2020 – Life Science Newswire – Pioneering research, which reveals digital chest drains generate and distribute less aerosol generated particles compared to traditional water seal systems, has been published  in the Seminars in Thoracic and Cardiovascular Surgery journal. The research was led by a team of thoracic consultants from Guy’s

    Hematoxylin compounds can specifically kill CALR mutant cancer cells

    Patients with myeloproliferative neoplasm (MPN), a group of malignant diseases of the bone marrow, often have a carcinogenic mutated form of the calreticulin gene (CALR). Researchers of the research team of Robert Kralovics, Adjunct Principal Investigator in the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and team leader at the

    IGC analysts get three out of six European Research Council grants

    Since the establishment of the European Research Council in 2008, the IGC has secured 17 of the competitive grants (7 Beginning, 8 Consolidator and two Advanced). In 2021, with the beginning of the new grants awarded this month, it will have ten active grants. The year of 2020 marks a total of 327 researchers chosen

    Cipla announces settlement of Revlimid® (Lenalidomide) capsules patent Litigation

    Mumbai, India, December 11, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) (“Cipla”) today announced the settlement of its litigation with Celgene Corporation, and wholly owned subsidiary of Bristol Myers Squibb (NYSE: BMY) relating to patents for REVLIMID® (lenalidomide). As part of the settlement, the Parties will file Consent Judgments with the United States District

    Study: Most pregnant patients tested positive for Covid were asymptomatic

    The pregnant patients who tested positive for the coronavirus were also more likely than those who tested negative to identify as Hispanic and report their primary language as Spanish. In a retrospective cross-sectional analysis of worldwide screenings for SARS-Cov-2, the virus which causes COVID-19, implemented in the labor and delivery unit of Elmhurst Hospital in

    Scepter™ 3.0 Instrument for Wireless Cell Counting Precision launched by Merck

    Merck announce the launch of its new Scepter™ 3.0 handheld automated cell counter, a solution that enables convenient, on-demand cell volume, cell diameter and cell concentration data. The device uses precision microfluidics to measure and count cells via electrical impedance within 30 seconds. The Scepter™ 3.0 cell counter offers researchers true automation without the risk